Clinical Trial Update: Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of moxifloxacin for treating community-acquired pneumonia with aspiration factors; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Beijing Hospital | Conditions: Community-Acquired Pneumonia | Phase 4 | Status: UNKNOWN